Triveni Bio
Focus: Triveni Bio is a precision medicine biotech focused on genetics-informed therapeutics in oncology and rare diseases, operating as a public company from Watertown, MA since 1993.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
4+3 this month
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Should You Work at Triveni Bio?
AI assessmentBest suited for scientists seeking precision-medicine exposure and strong VC backing, but limited hiring and opaque pipeline depth create execution uncertainty.
Why Work Here
- Recent $65M Series C funding (June 2026) signals strong investor confidence and provides runway for pipeline expansion.
- Perfect H1B sponsorship record (9 approvals, 0 denials in 2023) indicates established visa infrastructure for international talent.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TRIV-509
Atopic DermatitisRecent News · Triveni Bio(10)
Help build intelligence for Triveni Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.